-
Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL
de Boer, J. W., Keijzer, K., van Dorp, S., Mutsaers, P. G. N. J., Niezink, A. G. H., van Doesum, J. A., Serroukh, Y. I. M., Muntendam, L. W., Pulles, A. E., Kret, E. J., Sijs-Szabo, A., Oomen, J., Demandt, A. M. P., Stevens, W. B. C., Kuipers, M. T. & the Dutch CAR-T Tumorboard Consortium, 11 Nov 2025, In: Blood. 9, 21, p. 5641-5650 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Patient-Reported Outcomes of CAR T-Cell Therapy in Non-Hodgkin Lymphoma Patients and Their Impact on Survival
Spanjaart, A. M., Coz, E., Rioufol, C., Maucort-Boulch, D., Roche, S., Beijamini, V., Vledder, A., Ghesquieres, H., Kersten, M. J. & da Silva, M. G., 2025, (E-pub ahead of print) In: Transplantation and Cellular Therapy.Research output: Contribution to journal › Article › Academic › peer-review
-
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
Spanjaart, A. M., Ljungman, P., Tridello, G., Schwartz, J., Martinez-Cibrián, N., Barba, P., Kwon, M., Lopez-Corral, L., Martinez-Lopez, J., Ferra, C., di Blasi, R., Ghesquieres, H., Mutsaers, P., Calkoen, F., Jak, M., van Doesum, J., Vermaat, J. S. P., van der Poel, M., Maertens, J. & Gambella, M. & 22 others, , Sept 2024, In: Leukemia. 38, 9, p. 1985-1991 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
